A new trading day began on Monday, with Immuneering Corp (NASDAQ: IMRX) stock price up 4.59% from the previous day of trading, before settling in for the closing price of $1.09. IMRX’s price has ranged from $1.05 to $10.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -43.59% over the last five years. Meanwhile, its annual earnings per share averaged -2.39%. With a float of $21.00 million, this company’s outstanding shares have now reached $29.27 million.
The firm has a total of 68 workers. Let’s measure their productivity.
Immuneering Corp (IMRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immuneering Corp is 29.16%, while institutional ownership is 34.72%. The most recent insider transaction that took place on Apr 01 ’24, was worth 1,160,181. In this transaction 10% Owner of this company sold 400,000 shares at a rate of $2.90, taking the stock ownership to the 2,895,273 shares. Before that another transaction happened on Mar 22 ’24, when Company’s Director bought 25,000 for $2.55, making the entire transaction worth $63,713. This insider now owns 111,766 shares in total.
Immuneering Corp (IMRX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -2.39% per share during the next fiscal year.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Here are Immuneering Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Immuneering Corp (IMRX)
Analysing the last 5-days average volume posted by the [Immuneering Corp, IMRX], we can find that recorded value of 0.95 million was better than the volume posted last year of 0.94 million. As of the previous 9 days, the stock’s Stochastic %D was 5.76%. Additionally, its Average True Range was 0.15.
During the past 100 days, Immuneering Corp’s (IMRX) raw stochastic average was set at 4.29%, which indicates a significant decrease from 10.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.73% in the past 14 days, which was higher than the 95.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2945, while its 200-day Moving Average is $3.9501. Now, the first resistance to watch is $1.1767. This is followed by the second major resistance level at $1.2133. The third major resistance level sits at $1.2667. If the price goes on to break the first support level at $1.0867, it is likely to go to the next support level at $1.0333. Should the price break the second support level, the third support level stands at $0.9967.
Immuneering Corp (NASDAQ: IMRX) Key Stats
With a market capitalization of 33.80 million, the company has a total of 29,653K Shares Outstanding. Currently, annual sales are 0 K while annual income is -53,470 K. The company’s previous quarter sales were 0 K while its latest quarter income was -14,310 K.
